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To determine whether inhibition of PKC-b activity decreases pigmentation, paired cultures of primary human
melanocytes were ﬁrst pretreated with bisindolylmaleimide (Bis), a selective PKC inhibitor, or vehicle alone for 30
min, and then treated with TPA for an additional 90 min to activate PKC in the presence of Bis. Bis blocked the
expected induction of tyrosinase activity by activation of PKC. Addition of a peptide corresponding to amino acids
501–511 of tyrosinase containing its PKC-b phosphorylation site, a presumptive PKC-b pseudosubstrate, gave
similar results. To determine whether Bis reduces pigmentation in vivo, the backs of four shaved and depilated
pigmented guinea pigs were UV irradiated with a solar simulator for 2 wk excluding weekends. Compared to vehicle
alone, Bis (300 lM), applied twice daily to paired sites for various periods encompassing the irradiation period,
decreased tanning. Bis also, although less strikingly, reduced basal epidermal melanin when topically applied
twice daily, 5 d per wk, for 3 wk to shaved and depilated unirradiated skin. Moreover, topical application of Bis
(100 lM) once daily for 9 d to the freshly depilated backs of 8-wk-old mice markedly lightened the color of regrow-
ing hair. These results demonstrate that inhibiting PKC activity in vivo selectively blocks tanning and reduces
basal pigmentation in the epidermis and in anagen hair shafts.
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Pigmentation due to synthesis and dispersion of melanin
protects the skin from harmful effects of sunlight (Quevedo
and Holstein, 1998), but unwanted hyperpigmentation can
also produce a significant psychologic stress. Development
of effective therapeutics to modulate skin pigmentation has
been slow due to the complexity of molecular mechanisms
regulating pigmentation. Our laboratory has determined that
protein kinase C-b (PKC-b) activates tyrosinase (Park et al,
1993), the key and the rate-limiting enzyme in pigmentation
(Pawelek and Chakraborty, 1998), by phosphorylating
serine residues at amino acid positions 505 and 509 (Park
et al, 1999). Loss of PKC-b prevents melanogenesis in
cultured pigment cells (Yamanishi et al, 1991; Powell et al,
1993; Yamanishi and Meyskens, 1994; Park and Gilchrest,
1996; Park et al, 1999), suggesting that inhibition of this
isoform specifically or as part of pan-PKC inhibition might
lead to skin and hair lightening in vivo.
PKC is a family of serine/threonine kinases with at least
11 isoforms (Dekker and Parker, 1994), categorized as
classical PKC (cPKC), novel PKC (nPKC), and atypical PKC
(aPKC). PKC-b belongs to the category of cPKC, which also
includes PKC-a and PKC-g (Nishizuka, 1992). PKC-a is
ubiquitously expressed (Nishizuka, 1988) whereas the
expression of PKC-g is restricted to brain (Nishizuka,
1984), and PKC-b is expressed in many tissues, including
brain, endocrine tissues, liver, spleen, lung, heart, and testis
(Nishizuka, 1988). In skin, PKC-b expression appears to be
restricted to melanocytes (Park et al, 1991), whereas PKC-a
is expressed in melanocytes, keratinocytes, and fibroblasts
(Park et al, 1991; Racchi et al, 1994; Reynolds et al, 1994). In
general, PKC resides in the cytoplasm in an inactive form
and is activated when diacylglycerol (DAG) is generated
from the membrane when cell surface receptors interact
with their specific ligands (Nishizuka, 1984, 1992). Activa-
tion of cPKC requires the presence of both membrane-
generated DAG and elevated levels of intracellular Ca2þ
(Dekker et al, 1995; Newton, 1995; Nishizuka, 1995; Jaken,
1996), whereas DAG alone is sufficient to activate both
nPKC and aPKC (Dekker et al, 1995; Newton, 1995;
Nishizuka, 1995; Jaken, 1996). Activated PKC then translo-
cates to the plasma membrane or to another particular site
within the cell (Clemens et al, 1992; Leach and Raben, 1993;
Lehel, 1995a, 1995b; Dempsey et al, 2000) where it
phosphorylates its substrate protein(s).
The role of PKC in pigmentation was first suggested by
the observation that addition of DAG increased the melanin
level in cultured human melanocytes and the PKC inhibitors
H-7 and sphingosine blocked DAG-induced increases in the
level of melanin in these cells (Gordon and Gilchrest, 1989).
Topical application of DAG induced skin pigmentation in
guinea pigs in a reversible fashion, whereas a PKC-inactive
analog of DAG failed to induce skin pigmentation (Allan
et al, 1995), indicating that the activation of PKC increases
pigmentation in vitro and in vivo. Conversely, depletion of
Abbreviations: Bis, bisindolylmaleimide; TMP, tyrosinase
mimetic peptide.
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PKC by chronic treatment of cells with phorbol esters
markedly reduces the basal melanin level and tyrosinase
activity in human melanocytes (Park et al, 1993) and murine
S91 melanoma cells (Park et al, 1996). The PKC inhibitors
sphingosine and calphostine also block a-melanocyte
stimulating hormone induced pigmentation (Park et al,
1996), suggesting that the cAMP-dependent protein kinase
A pathway known to mediate a-melanocyte stimulating
hormone effects ultimately interacts with the PKC pathway.
Bisindolylmaleimide GF 109203X (Bis), a selective
inhibitor for cPKC (Toullec et al, 1991), is a synthetic
derivative (molecular weight 0.4 kDa) of the microbial
product staurosporine that exerts its effects at least partly
by competing with adenosine-50-triphosphate (Tamaoki
et al, 1986). Bis was shown to have higher selectivity for
PKC-b than for PKC-a and PKC-g, with an IC50 of 16 nM
versus an IC50 of 20 nM (Toullec et al, 1991; Davis et al,
1992), and a 10–100-fold higher IC50 for other isoforms of
PKC and for other serine/threonine and tyrosinase kinases
(Toullec et al, 1991; Martiny-Baron et al, 1993). In our study,
Bis reduced pigmentation in cultured human melanocytes,
reduced basal pigmentation, and prevented ultraviolet (UV)
induced increased melanogenesis (tanning) via topical
application in guinea pigs. In mice, topical application of
Bis to depilated skin lightened the color of regrowing hairs.
In the context of prior studies, these findings demonstrate
that inhibition of PKC-b activity reduces pigmentation in vivo
and in vitro.
Results
Competitive inhibition of PKC-b activity reduces tyrosi-
nase activity in vitro To test the hypothesis that inhibition
of PKC-b activity would decrease phosphorylation of
tyrosinase, and subsequently decrease tyrosinase activity,
a tyrosinase mimetic peptide (TMP) was employed. TMP is
composed of 11 amino acids whose sequence is identical
to amino acids 501–511 of tyrosinase (Kwon et al, 1987)
(Fig 1). A control peptide had identical sequence except for
alanines in place of serines, the known phosphorylation
sites for PKC-b (Park et al, 1999). Paired cultures of
subconfluent human melanocytes were treated with 3 mm
of TMP or control peptide for 16 h. To enhance their delivery,
TMP and control peptides were first treated with lipofecta-
mine for 30 min. Cells were then treated with 10–7 M TPA for
90 min to activate PKC, harvested, and analyzed for
tyrosinase activity. Compared to the cells treated with
control peptide, TMP-treated cells had significantly lower
tyrosinase activity (Fig 2A).
To confirm that TMP inhibits phosphorylation of tyrosi-
nase by PKC-b, paired plates were treated with 3 mm
control peptide or TMP for 16–18 h and subsequently
treated with 10–7 M TPA for 90 min in the presence of 32P-
orthophosphate to activate PKC. Then tyrosinase was
immunoprecipitated using a polyclonal antibody specific
for tyrosinase (Jimenez et al, 1991). Incorporation of 32P-
orthophosphate into tyrosinase was significantly less in
TMP-treated melanocytes than in control peptide-treated
melanocytes (Fig 2B). These results are consistent with
previous reports (Park et al, 1993, 1999) that tyrosinase
activity is modulated by PKC-b-mediated phosphorylation
and, in combination with the earlier reports, demonstrate
that PKC-b inhibition decreases this rate-limiting melano-
genic activity.
Inhibition of PKC activity with Bis decreases tyrosinase
activity in vitro To further demonstrate that inhibition of
PKC-b activity would reduce pigmentation, Bis, a commer-
cially available selective inhibitor for cPKC with minimal
effect on other serine/threonine kinases including nPKC and
aPKC or on tyrosine kinases (Toullec et al, 1991), was
employed. Paired subconfluent melanocyte cultures were
first treated with 50 mM Bis for 30 min, and then treated with
10–7 M TPA for an additional 90 min. Preliminary dose–
response studies using Bis concentrations of 1–100 mM
indicated that 50 mM was the optimal concentration to
inhibit TPA-induced increases in tyrosinase activity without
any visible effects on cell survival or morphology. Cells were
then harvested and tyrosinase activity was measured. The
TPA-induced increase in tyrosinase activity was blocked by
Bis treatment (Fig 3), further confirming that PKC-b activity
is necessary for tyrosinase activity, at least in vitro.
Effects of Bis on UV-induced skin pigmentation in
vivo To test whether inhibition of PKC-b activity in vivo
reduces skin pigmentation, pigmented guinea pigs were
employed as described in Materials and Methods. These
animals have melanocytes in the interfollicular epidermis
and are known to tan in response to UV irradiation (Allan et
al, 1995). Biopsies of the UV-irradiated sites taken 24 h after
the last exposure showed the expected increase in
epidermal melanin, as well as epidermal thickening (Fig
4A). In all four animals, topical application of Bis decreased
skin pigmentation in all application sites (Fig 5). There was
no erythema or other evidence of cutaneous irritation during
or after the application. Interestingly, the period of Bis
application (before, during, and after UV irradiation; during
and after only; or during only) did not affect the degree
of skin lightening. The effect of Bis on skin lightening
was consistently less on Site 1, located closest to the
head, however, compared to Sites 2 and 3, which displayed
both darker tanning and a more striking reduction in
Figure1
Amino acid sequences of the TMP and control peptide. Serine
residues, the site of PKC-b-mediated phosphorylation in TMP, are
highlighted. In the control peptide, serine is replaced by alanine, which
cannot be phosphorylated.
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pigmentation by Bis. This is consistent with our previous
observation that the cephalad part of the guinea pig back
does not pigment as darkly in response to UV irradiation or
other stimuli (Allan et al, 1995), and our reasoning that the
degree of observed pigment reduction resulting from PKC-b
inhibition depends on the basal or stimulated level of PKC-b
activity.
Bis decreased total epidermal melanin and tyrosinase
activity To assess the total amount of epidermal melanin in
each treatment site, the paraffin-embedded biopsies were
sectioned and stained with Fontana–Masson (silver nitrate).
There was a consistent decrease in total epidermal melanin
in Bis-treated areas compared to vehicle-treated areas (Fig
4B). Consistent with these results, split-dopa staining of en
face sections was far less in Bis-treated sites than vehicle-
treated sites (Fig 6).
In vivo reﬂectance confocal microscopy showed de-
creased melanin in Bis-treated sites In reflectance-mode
confocal imaging of skin, melanin is the best endogenous
contrast agent and melanin-containing cells are highly
refractile (Rajadhyaksha et al, 1995). When imaging pig-
mented guinea pig skin, melanocytes are easily identifiable
Figure 2
TMP inhibits tyrosinase activity by blocking phosphorylation of
tyrosinase by PKC-b. (A) Paired cultures of subconfluent melanocytes
were treated with 3 mm of TMP or control peptide for 16 h, then with 10–7
M TPA for 90 min to activate PKC, and then harvested. Tyrosinase
activity was measured as previously described (Pomerantz, 1964).
Student paired t test was employed for statistical analysis. (B) Paired
cultures of melanocytes were first treated with 3 mm TMP or control
peptide for 16 h, and then treated with 10–7 M TPA in DMEM without
phosphate in the presence of 32P-orthophosphate for 90 min. Cells
were harvested and tyrosinase was immunoprecipitated, using a
specific polyclonal antibody against tyrosinase. Immunoprecipitated
proteins were separated by subjecting them to 7.5% sodium dodecyl
sulfate polyacrylamide gel electrophoresis. The gel was dried and
exposed to Kodak X-OMAT film to demonstrate 32p-tyrosinase. A
representative result from two independent experiments is presented.
Figure3
Bis inhibits tyrosinase activity in cultured melanocytes. Paired
cultures of subconfluent melanocytes were first pretreated with 50 mm
Bis or vehicle for 30 min. Then the cells were treated with 10–7 M TPA
for an additional 90 min in the presence of Bis. Cells were then
harvested and tyrosinase activity was measured. A representative
result from three independent experiments is presented and Student
paired t test was used for statistical analysis.
Figure4
Bis blocks UV- or sham-induced increases in epidermal melanin.
Guinea pigs were treated and irradiated over a 2 wk period, as
described. Biopsies taken 24 h after the last irradiation were stained
with Fontana–Masson to visualize total epidermal melanin. (A) UV or
sham irradiation only; no topical treatment. (B) UV irradiation plus daily
treatment with Bis or vehicle alone. Representative sections from each
site are shown.
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by their white color and dendritic morphology (Wang et al,
2002). Animals were anesthetized and reflectance confocal
microscopy was performed once a week. As shown in Fig 7,
the UV-induced increase in melanin was clearly visible after
9 d. In nonirradiated skin, keratinocytes can be visualized in
the suprabasal layer as polygonal to round structures with a
dark nucleus surrounded by a brighter cytoplasm, whereas
in irradiated skin keratinocytes contain far more melanin,
seen as bright round spots (Fig 7). After 1 wk and more
striking after 2 wk, the overall brightness of keratinocytes
was clearly less in Bis-treated skin than in skin treated with
vehicle alone, consistent with the reduction of cutaneous
pigmentation observed clinically at the end of the irradiation
period and with the histologic determinations. Melanocytes
could be easily recognized at the basal layer level by their
brightness and dendricity, both in nonirradiated and in
irradiated skin. As expected, however, melanocytes in
irradiated skin were increased in number and size com-
pared to those in nonirradiated skin. Again, this difference
was less pronounced in Bis-treated skin than in vehicle-
treated skin. These results further confirm that inhibition of
PKC-b reduces pigmentation in vivo and demonstrate the
feasibility of performing detailed noninvasive time course
studies through serial examination of single animal or
human subjects.
Bis decreases basal skin pigmentation in vivo In order
to determine whether topical application of Bis would also
reduce basal pigmentation, the backs of three guinea pigs
were shaved and Naired. Bis (300 mM) or vehicle alone was
topically applied as described above and biopsies were
obtained 24 h after the last applications. Clinically, there
was only subtle lightening in the Bis-treated skin but
Fontana–Masson-stained sections from the Bis-treated
areas showed a significant reduction (po0.03) in epidermal
melanin compared to vehicle-treated areas as assessed by
image analysis (Fig 8A,B). Therefore, the effect of Bis is not
limited to UV-induced pigmentation. Rather, as anticipated
on the basis of the in vitro studies, Bis inhibits basal
pigmentation as well.
Effect of Bis treatment on murine coat color To
determine whether topical application of Bis would also
lighten hair color, Bis (100 mM) was applied once daily to
freshly depilated mice for 9 d, beginning on day 3 after
depilation. As the coat regrew, hair color was strikingly
lighter in Bis-treated but not in vehicle-treated areas (Fig 9).
The striking loss of coat pigmentation on casual inspection
was confirmed by examining individual hairs plucked from
vehicle-treated versus Bis-treated areas under the dissect-
ing microscope (Fig 9, inset).
Figure 5
Bis reduces skin pigmentation of guinea pigs. Four pigmented
guinea pigs were treated with Bis or vehicle as described in Materials
and Methods. After the last application, the hair was re-shaved and
photographs were taken to demonstrate the effect of Bis on
pigmentation.
Figure 6
Tyrosinase activity in vehicle- and Bis-treated skin. Guinea pigs
were treated and irradiated over a 2 wk period, as described. Biopsies
taken 24 h after the last application were processed for in vivo split-
dopa assay as described in Materials and Methods. Brown staining
indicates melanin in melanocyte dendrites. Bis-treated and vehicle-
treated skin from Site 2 is shown. Sites 1 and 3 showed comparable
differences.
Figure7
Reflectance-mode confocal microscopy of nonirradiated skin and
vehicle- and Bis-treated irradiated skin. Images from the suprabasal
and basal layer of skin show an overall decrease in brightness
(autofluorescence due to melanin present in keratinocytes and
melanocytes) of Bis-treated irradiated skin compared to vehicle-treated
irradiated skin, corresponding to a decrease in pigmentation. As seen
most easily in nonirradiated skin, the suprabasal layer shows the
characteristic honey-combed pattern created by keratinocytes with
central nuclei and relatively little cytoplasmic melanin, whereas the
image obtained at the basal layer is melanocytes that are easily
identified by their dendritic morphology. In irradiated vehicle-treated
(tanned) skin, both the suprabasal and basal layers of the epidermis
contain far more melanin (detected as bright areas) that obscure these
patterns. The irradiated Bis-treated skin is intermediate in melanin
content but more closely resembles the nonirradiated central images.
(In vivo confocal images, 30  water immersion objective lens, image
width corresponds to 250 mm.) The cartoon is modified from Daniels et
al (1968).
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Discussion
In combination with previous studies (Park et al, 1993,
1999), these results demonstrate that inhibition of PKC-b
activity reduces pigmentation both in vivo and in vitro by
preventing phosphorylation of tyrosinase. Although Bis, the
inhibitor employed for the in vivo studies, is not expected to
be completely selective for the b isoform of PKC (Toullec
et al, 1991), the only detected effects of Bis treatment were
those attributable to PKC-b inhibition on the basis of prior in
vitro studies. Cultured human melanocytes treated with the
PKC inhibitor Bis did not display any morphologic changes
other than decreased melanin content, and topical applica-
tion of Bis twice daily for up to 5 wk did not produce any
clinically or histologically detectable changes in guinea pig
skin other than decreased pigmentation. Skin biopsy cross-
sections obtained at the end of the experiment, 24 h after
the last application, confirmed that Bis caused no cytologic
damage, atrophy, irritation, or inflammation. Visual inspec-
tion, histologic analysis, and skin imaging by in vivo
reflectance confocal microscopy all demonstrated pigmen-
tation reduction by topical application of Bis with no other
detectable effect of the treatment. These findings suggest
that Bis minimally affects cell behaviors other than
melanogenesis, perhaps because of the relative selectivity
of Bis for PKC-b (Toullec et al, 1991), an isoform that
appears to be exclusively expressed in melanocytes in skin
(Park et al, 1991) and appears to act only by stimulating
melanogenesis (Park et al, 1993, 1996).
Our results further indicate that restricting Bis application
to the 2 wk UV irradiation period is sufficient to block
tanning. Additional applications, for 1 wk before irradiation
or 2 wk after irradiation, did not further decrease pigmenta-
tion. These results are consistent with the expectation that
PKC-b is most abundant and active in the period
immediately following UV irradiation, given that UV irradia-
tion upregulates the expression of PKC-b mRNA within 1 h
(Park and Gilchrest, 1999; Rubeiz et al, 2002) and UV
irradiation also rapidly increases the intracellular level of
DAG (Punnonen and Yuspa, 1992). Generation of DAG
would be expected to activate PKC-b immediately, leading
to the activation of tyrosinase. Our findings are also
consistent with those of Hallahan et al (1991) that UV
upregulates the proto-oncogenes c-jun and c-fos, known to
be regulated through the PKC-dependent pathway, and that
these inductions are inhibited by PKC inhibitors. The lower
activity of PKC-b in resting, unirradiated melanocytes
should result in Bis having less effect, as observed.
Topical application of Bis also reduced basal pigmenta-
tion. Despite a striking difference in melanin content
determined by Fontana–Masson staining of the sections
obtained from vehicle-treated versus Bis-treated areas,
however, there was only a subtle difference in pigmentation
clinically. This probably reflects the fact that melanin was
located primarily in the basal layer (Fig 8A), rather than also
substantially in the suprabasular layers, as in UV-irradiated
skin, given that melanin near the skin surface is perceived
as darker than melanin restricted to the basal layer
(Quevedo and Holstein, 1998).
Cultured human melanocytes express the a, b, d, e, and z
isoforms of PKC (Oka et al, 1995). Among these isoforms,
only PKC-b has a well-defined role in the biology of
melanocytes. The phorbol ester TPA was found to support
long-term growth of melanocytes (Eisinger and Marko,
1982, 1983) via downregulation, not activation of PKC as
was later shown (Brooks et al, 1991), although the growth
rate over a 2 wk period is not accelerated relative to that of
melanocytes cultured in an otherwise optimized medium
lacking pharmacologic modulators of PKC levels (Gilchrest
Figure 8
Bis reduces basal pigmentation. Guinea pigs were topically treated
with Bis or vehicle alone for 3 wk, as described. Biopsies taken 24 h
after the last application were stained with Fontana–Masson to
visualize total epidermal melanin. (A) Representative sections from
Bis- and vehicle- treated areas. (B) Percent epidermis occupied by
melanin on serial sections from Bis- and vehicle-treated areas
determined using computer-image analysis as previously described
(Bhawan et al, 1991). For statistical analysis, Student t test was
performed.
Figure9
Mouse coat color is lightened by Bis treatment. Nine-week-old
black mice were depilated to synchronize the hair cycle and initiate a
new anagen growth phase. Beginning 3 d later, either 100 mM of Bis
(top) or vehicle alone (bottom) was topically applied once a day for 9 d
and mice were photographed on day 13. Inset: Hairs from Bis- or
vehicle-treated areas were plucked on day 13 and photographed under
a dissecting microscope. Representative hairs (midshaft, approxi-
mately 0.3 mm in length) from 50 hairs plucked from each area are
shown.
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and Friedmann, 1987). Downregulation of PKC-a, -d, -e, and
-z has been associated with growth of melanocytic cells,
but a causal relationship was not established (Brooks et al,
1993; Oka et al, 1995).
PKC-a and PKC-b, classical PKCs, have similar
activation requirements (Nishizuka, 1992) and both phos-
phorylate substrate sequences of XRXXSXRX, where X is
any amino acid (Kemp and Pearson, 1990). The amino acid
sequence of TMP deviates considerably from this
sequence, and it remains to be determined whether TMP
is a pseudo-substrate only for PKC-b. Unique substrate
sequences have not yet been identified for any PKC
isoform.
Ideally, these studies would have been performed with an
agent known to be a completely specific inhibitor of PKC-b,
but no such agent now exists. The TMP peptide has the
same sequence as the portion of tyrosinase shown to be
phosphorylated exclusively by PKC-b in melanocytes, but it
remains unclear whether this specificity is a property of the
amino acid sequence or selective localization of PKC-b to
the melanosome membrane, adjacent to tyrosinase (Park
et al, 2000). Hence, TMP introduced into melanocytes with
lipofectamine may serve as a pseudo-substrate for other
PKC isoforms as well. Bis is described as a selective PKC-b
inhibitor (Toullec et al, 1991) but at the concentrations
employed in our experiments might easily have also
inhibited PKC-a, the other cPKC isoforms expressed in
both melanocytes and other cell types in skin, notably
keratinocytes. Although the exact mechanism of action has
not been elucidated, PKC-a has been implicated in the
proliferation and differentiation of cultured keratinocytes
(Gherzi et al, 1992; Stanwell et al, 1996; Lee et al, 1998).
Therefore, topical application of Bis might influence
keratinocyte behavior as well as reduce pigmentation
through its effects on melanocytes. Despite this ambiguity,
however, these data demonstrate that PKC inhibition either
in isolated melanocytes or in intact skin reduces pigmenta-
tion without having other detectable effects after up to 5 wk
of application.
In addition to blocking UV-induced pigmentation and
reducing basal pigmentation in the epidermis, inhibition of
PKC-b activity also lightened mouse coat color, indicating
that Bis penetrates not only into the viable epidermis but
also into the follicular root sheath. One application per day
almost totally blocks melanogenesis during the anagen
phase of the hair cycle.
Although not studied in these experiments, it is likely that
the effects of Bis on pigmentation are reversible. The half-
life and stability of Bis in tissues have not been determined,
but the effects of Bis on PKC activity appear to be transient
(Toullec et al, 1991), implying that its effect is reversible.
Supporting this idea, the activation of PKC by DAG, known
to have a short half-life (Nishizuka, 1984), increases
pigmentation in guinea pig skin in a reversible fashion (Allan
et al, 1995).
In summary, we have demonstrated that topical applica-
tion of a PKC inhibitor reduces skin pigmentation in vivo, an
effect attributable specifically to PKC-b inhibition. Topical
application of such inhibitors may prove beneficial in
treating unwanted hyperpigmentation of human skin and/
or in lightening hair color.
Materials and methods
Cell culture Primary human melanocytes were cultured from
neonatal foreskins as previously described (Park et al, 1999). In
brief, the epidermis was separated from the dermis after overnight
incubation in 0.25% trypsin at 41C. Primary cultures of melano-
cytes were established by seeding 0.5–1  106 total epidermal
cells per 100 mm dish in Medium 199 supplemented with 10 mg per
mL insulin, 10–9 M triiodothyronine, 10 mg per mL transferrin,
1.4  10–6 hydrocortisone, 80 mM dbcAMP, bovine pituitary extract
(35 mg per mL), basic fibroblast growth factor (10 ng per mL),
epidermal growth factor (100 ng per mL), and 1%–2% fetal bovine
serum. All post primary cultures were maintained in a low calcium
(0.03 mM) version of this medium known to selectively support
melanocyte growth (Naeyaert et al, 1991). Cells at first to third
passage were used for all experiments.
UV irradiation The solar simulator consisted of a 1000 W xenon
arc lamp (Oriel, Stratford, CT), equipped with a WG 305 cut-on filter
(Schott, Germany). The irradiance as measured by an IL 1700
research radiometer (International Light, Newburyport, MA) fitted
with a UVB probe (SED 240, serial number 2093, SCS 280 UVB
1#5440, W#3790) was 0.17 mW per cm2 (or 1.7  10–4 W). The
animals were anesthetized with 0.3 mL of a mixture of 0.75 mL
ketamine (50 mg per mL, Bedford Laboratories, Bedford, OH) and
0.15 mL xylazine (100 mg per mL, Lloyd Laboratories, Shenan-
doah, IA) and irradiated through an adhesive template exposing
three paired 3.2 cm2 skin sites daily during 7 d for 14 min and 42 s
(150 mJ per cm2), a protocol previously shown to cause dark
tanning (Allan et al, 1995).
Tyrosinase activity Tyrosinase activity was measured according
to Pomerantz (1964). In brief, 5  105 cells were briefly sonicated
in 80 mM PO4 (pH 6.8) containing 1% Triton-X-100, and tyrosinase
was extracted for 60 min at 41C. 10–50 mg of cellular protein was
incubated with 250 nM L-tyrosine, 25 nM L-dihydroxyphenylala-
nine, 12.5 mg chloramphenicol, and 5 mCi of L-[3,5-3H] tyrosine (40–
60 Ci per mmol) for 30–60 min at 371C. The reaction was stopped
by addition of 500 mL of 10% trichloroacetic acid containing 0.2%
bovine serum albumin. Trichloroacetic acid soluble material was
reacted with Norit A and released 3H2O was measured using a
scintillation counter. The activity was expressed as counts per
minute of 3H2O released per microgram protein per hour minus the
nonspecific incorporation of radioactivity, determined by using
lysate boiled for 30 min (background, generally less than 5%–10%
of the sample).
Phosphorylation of tyrosinase Phosphorylation of tyrosinase in
cultured melanocytes was performed as previously described
(Park et al, 1999). Cultured melanocytes were preincubated
overnight with serum-free Dulbecco’s modified Eagle’s medium
(DMEM) devoid of phosphate, containing 50 mM sodium vanadate
and [32P]-orthophosphate (8500–9120 Ci per mmol). Then cells
were treated with 12-0-tetradecanoyl-phorbol-13 acetate (TPA)
10–7 M for 90 min to activate PKC and lyzed in a buffer containing
20 mM Tris (pH 7.5), 200 mM NaCl, 1% Triton X-100, 2 mM
ethylenediamine tetraacetic acid, 2 mM ethyleneglycol-bis(b-
aminoethyl ether)-N,N,N0,N0-tetraacetic acid, 0.5 mg per mL apro-
tinin, and 1 mM phenylmethylsulfonyl fluoride. The lysate was
clarified by spinning at 800  g for 15 min, and tyrosinase was
immunoprecipitated from the supernatant using polyclonal anti-
body specific for tyrosinase (Jimenez et al, 1991). Immunoprecipi-
tated proteins were separated using 7.5% sodium dodecyl sulfate
gel electrophoresis, dried, and exposed to Kodak X-OMAT film.
Animals Outbred pigmented guinea pigs, American Shorthair X
Abyssinian (Kuiper Rabbit Ranch, Chicago, IL), aged 12–20 wk at
the beginning of the study, were used. The animals had free access
to guinea pig chow and chlorinated water and were housed in
individual cages. Prior to topical applications, each animal was
shaved with an electric clipper (Oster, number 40 blade) to remove
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the long hair. The remaining stubble was removed with the
commercially available depilatory Nair (Carter-Wallace).
Experimental protocol All protocols were approved by the
Institutional Animal Care and Use Committee at Boston University
School of Medicine. Three separate protocols were employed to
study different aspects of pigmentation. To study effects of Bis on
UV-induced pigmentation, three pairs of treatment sites (3.2 cm2)
were chosen in areas of comparable baseline pigmentation on the
left and right sides of the back, equidistant from the dorsal midline,
for subsequent daily applications and UV exposure. The left sites of
each pair were treated with vehicle alone (25% dimethylsulfoxide,
75% propylene glycol) and the right sites with 300 mm Bis twice a
day. The Site 1 pair was treated for 1 wk before UV irradiation, 2 wk
during irradiation, and 2 wk after irradiation. The Site 2 pair was
treated twice daily during 2 wk of UV irradiation and 2 wk after
irradiation. The Site 3 pair was treated only during 2 wk of
irradiation. Weekends were excluded from applications. These
three protocols were included to account for the possibilities that
some time may be required for Bis to penetrate stratum corneum
and reach melanocytes, Bis might be expected to be most
effective during the UV irradiation period when PKC is known to be
induced (Park and Gilchrest, 1999; Rubeiz et al, 2002), and some
time may be required for PKC levels to return to their basal level
after irradiation. Photographs were taken and in vivo reflectance
confocal laser microscopy was performed during and after the
period of application. A higher concentration of Bis (300 mM) was
used for in vivo than for studies in vitro in light of the fact that the
compound needs first to penetrate the stratum corneum before
reaching the target melanocytes.
The possibility that Bis might act as a sunscreen was excluded
by metering UV transmittance through the 300 mM Bis preparation
versus vehicle alone, applied as an even film to tissue culture
plastic. There was no significant difference in transmittance: 0.15
mW vs 0.14 mW in the UVB range and 30 mW vs 28 mW in the UVA
range for vehicle versus Bis preparations, respectively.
To study the effects of Bis on basal pigmentation, backs of
three guinea pigs were shaved and depilated using Nair as
described above. One pair of treatment sites (3.2 cm2) in the
mid-back was treated with either vehicle or Bis (300 mM) twice daily
5 d per wk for 3 wk.
To study the effect of Bis on hair pigmentation, 7–8-wk-old
black female mice (C57BL/6) were anesthetized with a ketami-
nexylosine mixture (80 mg per kg and 16 mg per kg of body
weight, respectively) to depilate the entire back using a wax-rosin
mixture as previously described (Stenn et al, 1993). Bis (100 mM)
was applied on the cephalad half of the back and vehicle alone
was applied to the caudal half of the back beginning 3 d after
depilation once daily for 9 d. The 100 mM Bis concentration was
employed because skin barrier function is known to be less
efficient in mice than in guinea pigs. Photographs were taken to
document the color of regrowing hair 24 h after the last application.
In vivo reﬂectance confocal laser microscopy A commercially
available reflectance-mode confocal microscope (Vivascope 1000,
Lucid, Henrietta, NY) equipped with an 830 nm diode laser with a
maximal power of 25 mW and a 30  objective lens of numerical
aperture 0.9 was used for imaging skin of the anesthetized guinea
pigs. Technical details of the microscope and the imaging
procedure have been previously described (Rajadhyaksha et al,
1995, 1999). Briefly, the skin is immobilized against the microscope
by a ring-template fixture, so the laser beam is directed
perpendicular to the skin. Horizontal movement of the beam
allows screening of the skin site, whereas axial movement of the
beam results in a continuum of en face images from stratum
corneum to upper papillary dermis. The images, equivalent to
optical sections, have a lateral resolution of 0.5–1 mm and a section
thickness (axial resolution) of 3–5 mm, similar to conventional
histology. The immersion medium used for imaging was water, as
the refractive index of water is closest to that of skin, thereby
reducing artefacts during imaging. Animals were anesthetized
during confocal microscopy to minimize motion during imaging,
which was performed once a week. All imaging procedures were
video-taped and transferred to a computer. Still images were
grabbed at the level of the suprabasal layer to visualize spinous
keratinocytes and at the level of the basal layer to visualize basal
keratinocytes and melanocytes. The VivaScope user interface is
driven by a Windows NT based personal computer with menu-
driven software for initiating and controlling the scanners, laser
illumination power, z-depth focusing, and image capture.
Histologic analysis Punch biopsies (4 mm) were taken from
vehicle-treated and Bis-treated skin 24 h after the last application.
Specimens were fixed in 10% neutral-buffered formalin for 24 h,
dehydrated, and embedded according to standard histologic
protocols. Vertical cross-sections, stained with both hematoxylin
and eosin and Fontana–Masson silver nitrate were examined under
10  and 40  magnification using an Olympus BH-2 microscope
as previously described (Allan et al, 1995). The amount of
interfollicular epidermis occupied by melanin in serial sections
was quantitated by computer-image analysis as previously
described (Bhawan et al, 1991).
In vivo split-dopa staining Separate punch biopsies (4 mm) were
taken simultaneously from vehicle-treated skin and Bis-treated
skin to determine whether tyrosinase activity is reduced by
application of Bis in vivo. Each biopsy was placed onto a coverslip,
epidermal side down in a thin layer of permount. The biopsy was
then covered with 2 M sodium bromide solution for 2 h at 371C.
Dermis was then removed from the epidermis, and the coverslip
was rinsed with 0.1 M sodium phosphate buffer (pH 7.4) three
times. The entire coverslip with the epidermal sheet was immersed
in 0.1% deoxyphenylalanine solution at 371C for 4–6 h, changing
solution after the first 30 min and then every 2 h. The epidermis
was checked under the microscope every hour until a dark brown
color developed in at least one of the paired sections. The stained
epidermis of all paired specimens was then fixed in 10% formalin.
This study was funded in part by grants from the NIH (RO1 CA72763 to
HYP) and the Carl J. Herzog Foundation (to BAG). We would like to
thank Dr Richard Laursen at Boston University Department of
Chemistry for provision of the TMP and control peptides. Polyclonal
antibody against tyrosinase was kindly provided by Dr Vincent Hearing
at the National Institutes of Health.
DOI: 10.1046/j.0022-202X.2003.22134.x
Manuscript received March 13, 2003; revised June 4, 2003; accepted
for publication August 9, 2003
Address correspondence to: Hee-Young Park, PhD, Department of
Dermatology, J205, Boston University School of Medicine, 609 Albany
Street, Boston, MA 02118. Email: hypark@bu.edu
References
Allan AE, Archambault M, Messana E, Gilchrest BA: Topically applied
diacylglycerols increase pigmentation in guinea pig skin. J Invest
Dermatol 105:687–692, 1995
Bhawan J, Gonzalez-Serva A, Nehal K, Labadie R, Lufrano L, Thorne EG,
Gilchrest BA: Effects of tretinoin on photodamaged skin, a histologic
study. Arch Dermatol 127:666–672, 1991
Brooks G, Wilson RE, Dooley TP, Goss MW, Hart IR: Protein kinase C down-
regulation, and not transient activation, correlates with melanocyte
growth. Cancer Res 51:3281–3288, 1991
Brooks G, Goss MW, East JA, Hart IR: Growth of melanocytic cells is associated
with down-regulation of protein kinase C a, d, and e isoforms. Possible
role of diacylglycerol. J Biol Chem 268:23868–23875, 1993
PKC INHIBITOR REDUCES PIGMENTATION 165122 : 1 JANUARY 2004
Clemens MJ, Trayner I, Menaya J: The role of protein kinase C isoenzymes in the
regulation of cell proliferation and differentiation. J Cell Sci 103:881–887,
1992
Daniels F Jr, van der Leun JC, Johnson BE: Sunburn. Sci Am 219:38–46, 1968
Davis PD, Hill CH, Lawton G, et al: Inhibitors of protein kinase C. 1, 2, 3-
Bisarylmaleimides. J Med Chem 35:177–184, 1992
Dekker LV, Parker PJ: Protein kinase C–a question of specificity. Trends Biochem
Sci 19:73–77, 1994
Dekker LV, Palmer RH, Parker PJ: The protein kinase C and protein kinase C
related gene families. Curr Opin Struct Biol 5:396–402, 1995
Dempsey EC, Newton AC, Mochly-Rosen D, Fields AP, Rayland ME, Insel PA,
Messing RO: Protein kinase C isozymes and the regulation of diverse cell
responses. Am J Physiol Lung Cell Mol Physiol 279:429–L438, 2000
Eisinger M, Marko O: Selective proliferation of normal human melanocytes in vitro
in the presence of phorbol ester and cholera toxin. Proc Natl Acad Sci
USA 79:2018–2022, 1982
Eisinger M, Marko O: Stimulation of growth of human melanocytes by tumor
promoters. Carcinogenesis 4:779–781, 1983
Gherzi R, Sparatore B, Patrone M, Sciutto A, Briata P: Protein kinase C mRNA
levels and activity in reconstituted normal human epidermis: Relation-
ships to cell differentiation. Biochem Biophys Res Comm 184:283–291,
1992
Gilchrest BA, Friedmann PS: A culture system for study of human melanocyte
physiology. In: Jimbow K (ed.) Structure and Function of Melanin. Vol 4.
Sapporo, Japan: Fuji-Shoin Co. Ltd, 1987: pp 1–13
Gordon PR, Gilchrest BA: Human melanogenesis is stimulated by diacylglycerol.
J Invest Dermatol 93:700–702, 1989
Hallahan DE, Virudachalam S, Sherman ML, Huberman E, Kufe DW, Weichsel-
baum RR: Tumor necrosis factor gene expression is mediated by protein
kinase C following activation by ionizing radiation. Cancer Res 51:4565–
4569, 1991
Jaken S: Protein kinase C isozymes and substrates. Curr Opin Cell Biol 8:
168–173, 1996
Jimenez M, Tsukamoto K, Hearing VJ: Tyrosinases from two different loci are
expressed by normal and by transformed melanocytes. J Biol Chem
266:1147–1156, 1991
Kemp BE, Pearson RB: Protein kinase recognition sequence motifs. Trends
Biochem Sci 15:342–346, 1990
Kwon BS, Haq AK, Pomerantz SH, Halaban R: Isolation and sequence of a cDNA
clone for human tyrosinase that maps at the mouse c-albino locus. Proc
Natl Acad Sci 84:7473–7477, 1987
Leach KL, Raben DM: Nuclear localization of protein kinase C. Biochem Soc
Trans 21:879–883, 1993
Lee YS, Yuspa SH, Dlugosz AA: Differentiation of cultured human epidermal
keratinocytes at high cell densities is mediated by endogenous activation
of the protein kinase C signaling pathway. J Invest Dermatol 111:762–
766, 1998
Lehel C, Olah Z, Jakab G, et al: Protein kinase C e subcellular localization
domains and proteolytic degradation sites: A model for protein kinase C
conformational changes. J Biol Chem 270:19651–19658, 1995a
Lehel C, Olah Z, Jakab G, Anderson WB: Protein kinase C e is localized to the
Golgi via its zinc-finger domain and modulates Golgi function. Proc Natl
Acad Sci USA 92:1406–1410, 1995b
Martiny-Baron G, Kazanietz MG, Mischak H, et al: Selective inhibition of protein
kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem
268:9194–9197, 1993
Naeyaert JM, Eller MS, Gordon PR, Park HY, Gilchrest BA: Pigment content of
cultured human melanocytes does not correlate with tyrosinase message
level. Br J Dermatol 125:297–303, 1991
Newton AC: Protein kinase C: Structure, function, and regulation. J Biol Chem
270:28495–28498, 1995
Nishizuka Y: Turnover of inositol phospholipids and signal transduction. Science
225:1365–1370, 1984
Nishizuka Y: The molecular heterogeneity of protein kinase C and its implication
for cellular regulation. Nature 334:661–665, 1988
Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation
of protein kinase C. Science 258:607–614, 1992
Nishizuka Y: Protein kinase C and lipid signaling for sustained cellular responses.
FASEB J 9:484–496, 1995
Oka M, Ogita K, Ando H, Kikkawa U, Ichihashi M: Differential down-regulation of
protein kinase C subspecies in normal human melanocytes: Possible
involvement of the Zeta subspecies in growth regulation. J Invest
Dermatol 105:567–571, 1995
Park HY, Gilchrest BA: Reduction of melanogenic activity and responsiveness to
a-melanocyte stimulating hormone during serial passage of melanoma
cells. J Cut Med Surg 1:4–9, 1996
Park HY, Gilchrest BA: Signaling pathways mediating melanogenesis. Cell Mol
Biol 45:919–930, 1999
Park HY, Russakovsky V, Apgar J, Gilchrest BA: Cell-specific and age dependent
expression of protein kinase C in human skin-derived cells. Clin Res
39:148A, 1991
Park HY, Russakovsky V, Ohno S, Gilchrest BA: The b isoform of protein kinase C
stimulates human melanogenesis by activating tyrosinase in pigment
cells. J Biol Chem 268:11742–11749, 1993
Park HY, Russakovsky V, Ao Y, Fernandez E, Gilchrest BA: a-Melanocyte
stimulating hormone-induced pigmentation is blocked by depletion of
protein kinase C. Exp Cell Res 227:70–79, 1996
Park HY, Perez JM, Laursen R, Hara M, Gilchrest BA: Protein kinase C-b activates
tyrosinase by phosphorylating serine residues in its cytoplasmic domain.
J Biol Chem 274:16470–16478, 1999
Park HY, Wu HW, Young D, Gilchrest BA: PKC-b is associated with its receptor
RACK-1 at the melanosomal surface in human melanocytes (abstr). J
Invest Dermatol 114:787, 2000
Pawelek JM, Chakraborty AK: The enzymology of melanogenesis. In: Nordlund
JJ, Boissy RE, Hearing VJ, King RA, Ortonne JP (eds.) The Pigmentary
System. New York: Oxford University Press, 1998, pp 391
Pomerantz SH: Tyrosinase hydroxylation catalyzed by mammalian tyrosinase. An
improved method of assay. Biochem Biophys Res Comm 16:188–194,
1964
Powell MB, Rosenberg RK, Graham MJ, Birch ML, Yamanishi DT, Buckmeier JA,
Meyskens FL Jr. et al: Protein kinase C b expression in melanoma cells
and melanocytes: Differential expression correlates with biological
responses to 12-O-tetradecanoylphorbol 13-acetate. J Cancer Res Clin
Oncol 119:199–206, 1993
Punnonen K, Yuspa SH: Ultraviolet light increases cellular diacylglycerol and
induces translocation of diacylglycerol kinase in murine keratinocytes. J
Invest Dermatol 99:221–226, 1992
Quevedo WC, Holstein TJ: General biology of mammalian pigmentation. In:
Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne JP (eds.) The
Pigmentary System. New York: Oxford University Press, 1998; p 43–58
Racchi M, Bergamaschi S, Govoni S, et al: Characterization and distribution of
protein kinase C isoforms in human skin fibroblasts. Arch Biochem
Biophys 314:107–111, 1994
Rajadhyaksha M, Grossman M, Esterowitz D, Webb RH, Anderson RR: In vivo
confocal scanning laser microscopy of human skin: Melanin provides
strong contrast. J Invest Dermatol 104:946–952, 1995
Rajadhyaksha M, Gonza´lez S, Zavislan JM, Anderson RR, Webb RH: In vivo
confocal scanning laser microscopy of human skin II. Advances in
instrumentation and comparison with histology. J Invest Dermatol
113:293–303, 1999
Reynolds NJ, Baldassare JJ, Henderson PA, et al: Translocation and down-
regulation of protein kinase C isoenzymes-a and -e by phorbol ester and
bryostatin-1 in human keratinocytes and fibroblasts. J Invest Dermatol
103:364–369, 1994
Rubeiz N, Park HY, Gilchrest BA: Protein kinase C-b is induced in ionizing
irradiation induced pigmentation. J Photosci 9:209–212, 2002
Stanwell C, Denning MF, Rutberg SE, Cheng C, Yuspa SH, Dlugosz AA:
Staurosporine induces a sequential program of mouse keratinocyte
terminal differentiation through activation of PKC isozymes. J Invest
Dermatol 106:482–489, 1996
Stenn KS, Paus R, Dutton T, Sarba B: Glucocorticoid effect on hair initiation: A
reconsideration. Skin Pharmacol 6:125–134, 1993
Tamaoki T, Nomoto H, Takahashi I, Kato Y, Morimoto M, Tomita F: Staurosporine,
a potent inhibitor of phospholipid/ca++ dependent protein kinase.
Biochem Biophys Res Commun 135:397–402, 1986
Toullec D, Pianetti P, Coste H, et al: The bisindolylmaleimide GF 109203X is a
potent and selective inhibitor of protein kinase C. J Biol Chem
266:15771–15781, 1991
Wang L, Demirs JT, Pathak M, Gonzalez S: Real-time, in vivo quantification of
melanocytes by near-infrared reflectance confocal microscopy in the
guinea pig animal model. J Invest Dermatol 119:533–535, 2002
Yamanishi DT, Meyskens FL Jr: Alterations in gene expression and signal
transductions in human melanocytes and melanoma cells. Crit Rev Oncol
5:429–450, 1994
Yamanishi DT, Graham M, Buckmeier JA, Meyskens FL Jr: The differential
expression of protein kinase C genes in normal human neonatal
melanocytes and metastatic melanomas. Carcinogenesis 12:105–109,
1991
166 PARK ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
